KRTAP10-7

Across TCGA pan-cancer cohorts, KRTAP10-7 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated KRTAP10-7 data layer compared with 6 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher KRTAP10-7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated KRTAP10-7 expression acts as an unfavorable survival marker, although some lineages such as LUSC show a favorable association.

LUAD, CHOL, and THYM are the cancer types where KRTAP10-7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	II,III,IV	0.292	0.664	.001	54	view →
CHOL	DFS	Tertile	All	0.045	0.486	.009	45	view →
THYM	DFS	Tertile	All	0.268	0.830	.004	33	view →
SKCM	OS	Tertile	All	0.118	0.328	.001	24	view →
COAD	OS	Tertile	All	0.676	0.883	.013	24	view →
TGCT	DFS	Tertile	All	0.670	0.880	.003	22	view →
ESCA	DFS	Tertile	All	0.364	0.539	.011	20	view →
THCA	DFS	Tertile	II,III,IV	0.211	0.752	.012	12	view →
LUSC	DFS	Tertile	II,III,IV	1.000	0.375	.024	12	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
LGG	OS	Tertile	All	0.516	0.839	.003	9	view →
GBM	OS	Tertile	All	0.207	0.425	.017	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

KRTAP10-7–LUAD (DFS)

Open the LUAD breakdown →